Treatment of gefitinib-associated folliculitis - 09/08/11
Doi : 10.1016/j.jaad.2006.06.034
Patricia Matheis, MD a, Mark A. Socinski, MD b, Craig Burkhart, MD a, Simon Warren, MD a, Nancy E. Thomas, MD, PhD a, ⁎ 
a From the Departments of Dermatology
b Oncology, University of North Carolina at Chapel Hill
Reprint requests: Nancy E. Thomas, MD, PhD, Department of Dermatology, University of North Carolina at Chapel Hill, 3100 Thurston Bowles Bldg, CB No. 7287, Chapel Hill, NC 27599.Chapel Hill, North Carolina
Abstract |
Gefitinib (Iressa), an epidermal growth factor inhibitor approved for treatment of advanced nonsmall cell lung carcinoma, is associated with an acneiform distributed folliculitis. Treatment attempts for this folliculitis have been noted in the literature, but photodocumentation of results has not been reported. We report 3 consecutive cases of gefitinib-associated folliculitis with photodocumentation of their treatment responses to combination therapy with topical metronidazole and oral tetracyclines.
Le texte complet de cet article est disponible en PDF.Plan
| Funding sources: None. Conflicts of interest: None identified. |
© 2006
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 55 - N° 4
P. 710-713 - octobre 2006 Retour au numéro
Article précédent
- Cyclosporine in chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial
- Gino A. Vena, Nicoletta Cassano, Delia Colombo, Elena Peruzzi, Paolo Pigatto, the NEO-I-30 Study Group ∗
- Borderline tuberculoid leprosy in a woman from the state of Georgia with armadillo exposure
- Joshua E. Lane, Douglas S. Walsh, Wayne M. Meyers, Mary K. Klassen-Fischer, David E. Kent, David J. Cohen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?